Navigation Links
CorMatrix Cardiovascular to Present Data on Its Next Generation ECM Technology(TM) at Annual Transcatheter Cardiovascular Therapeutics (TCT) Conference in Washington, D.C.
Date:10/10/2008

WASHINGTON, Oct. 10 /PRNewswire/ -- CorMatrix Cardiovascular, Inc., an Atlanta-based company dedicated to developing and delivering unique extracellular matrix (ECM(TM)) biomaterial devices that harness the body's innate ability to repair damaged cardiovascular tissue, today announced that Robert G. Matheny, M.D., Chief Scientific Officer, will present data on the company's next generation ECM Technology(TM) at the annual Transcatheter Cardiovascular Therapeutics (TCT) 2008 conference in Washington, D.C. next week.

The presentation entitled "Cell Therapy Devices and Concepts: Acellular Matrix Emulsion Injections to Induce Myofibroblast Proliferation and Angiogenesis" will take place on Monday, October 13th at 1:35 p.m. EDT in room 145AB as part of the Innovative Devices and Futuristic Therapies Session.

"We are very proud to have Dr. Matheny included to present preclinical data from our next generation product within this prestigious panel," commented Beecher Lewis, President and Chief Operating Officer of CorMatrix Cardiovascular. "Our inclusion in this session reinforces the fact that our technology continues to gain interest and acceptance among the cardiovascular community."

About CorMatrix ECM Technology(TM)

CorMatrix Cardiovascular holds an exclusive license from Purdue University to research, develop, manufacture and market naturally occurring ECM products for cardiovascular applications. The company currently has U.S. clearance and European approval with a CE Mark to market its ECM Technology as an implant for pericardial closure, clearance in the U.S. for cardiac tissue repair, and is conducting preclinical studies on a number of cardiovascular applications including an emulsified, injectible form of its ECM Technology as a potential treatment for heart failure.

About CorMatrix Cardiovascular, Inc.

CorMatrix Cardiovascular, a privately held company based in Atlanta, Georgia, is dedicated to developing and del
'/>"/>

SOURCE CorMatrix Cardiovascular, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. CorMatrix(R) Announces FDA 510(k) for Novel Biomaterial Implant for Intracardiac Repair
2. Core Laboratories Joint Venture Agreement Between genae associates, VIBGYOR Scientific Research, Cardiovascular Center Aalst and J.B. Dahm
3. Physician to Implant the CATANIA(TM) Coronary Stent System With Polyzene(R)-F to Treat Chronic Total Occlusion During Live Case at the Paris Cardiovascular Interventions Course (Francophone) 2008
4. Nuvelo and ARCA biopharma Announce Merger Agreement Creating Late-Stage Cardiovascular Biotechnology Company
5. VIA Pharmaceuticals to Host Investor Science Briefing on the Role of Inflammation in Cardiovascular Disease on Tuesday, September 16
6. Terumo Cardiovascular Systems Files Patent Infringement Complaint Against Maquet Affiliates
7. Expert Consensus Panel Recommendation for Incorporating Lp-PLA2 Testing into Cardiovascular Disease Risk Assessment Guidelines
8. HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker
9. The Gladstone Institutes and iZumi Bio Announce Broad Partnership in Regenerative Medicine and Cardiovascular Disease
10. Stable Stroke Patients More Likely to Die From a Nonstroke Cardiovascular Event Than a Further Stroke
11. CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 2014  WIRB-Copernicus Group (WCG), the world,s largest ... clinical research, announced today that its Western Institutional ... by the Association for the Accreditation of Human ... safeguards for clinical research participants. WCG ... Ph.D., commented, "It is of utmost importance to ...
(Date:9/22/2014)... Mass. , Sept. 22, 2014 ... GEVA ), a biopharmaceutical company developing therapeutic ... of Robert Bazemore as Chief Operating ... , President and Chief Executive Officer, Robert will ... company,s lead program, sebelipase alfa for LAL Deficiency, ...
(Date:9/21/2014)... For the first time, scientists have discovered how to ... strength and stiffness greater than that of today,s strongest ... a research team led by John V. Badding, a ... published in the 21 September 2014 issue of the ... point of view, our discovery is intriguing because the ...
(Date:9/20/2014)... September 20, 2014 HealthTronics, ... and interventional radiology products and services, has signed ... with Clinicon Corporation for its high ... portfolio of minimally invasive, mobile, surgical technology—offering more ... Under the agreement, HealthTronics will make available Clinicon’s ...
Breaking Biology Technology:Western IRB (WIRB) Awarded AAHRPP Reaccreditation 2Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer 2Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer 3Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer 4Smallest possible diamonds form ultra-thin nanothreads 2Smallest possible diamonds form ultra-thin nanothreads 3Smallest possible diamonds form ultra-thin nanothreads 4HealthTronics Announces Distribution Agreement with Clinicon-Laser Surgical Device Expands Minimally Invasive, Mobile Technology Portfolio 2HealthTronics Announces Distribution Agreement with Clinicon-Laser Surgical Device Expands Minimally Invasive, Mobile Technology Portfolio 3
... - In an effort to spur growth in ... Wisconsin-Whitewate r graduates, the city of Whitewater ... UW-Whitewater are developing a business incubator, according to a ... which last year received a $10,000 state grant to ...
... where I served as a judge for an industry award contest. ... were locked in a conference room at the Sheraton at ... diligently selected the winners of this year's Medical Design Excellence ... much more recognition, the MDEA winners may very well save your ...
... Corp. has signed a definitive agreement to acquire ... in Quebec City, Canada. , ,Terms of the deal ... close by the end of February. , ,RedPrairie, ... will operate under the RedPrairie name, and RedPrairie's Global ...
Cached Biology Technology:And the winners in medical design are 2And the winners in medical design are 3And the winners in medical design are 4And the winners in medical design are 5And the winners in medical design are 6
(Date:9/22/2014)... will gather in Vancouver, British Columbia, Canada, to present ... Annual Meeting & Exposition on 19-22 October 2014. Special ... crude oil, earthquake prediction problems, and how to land ... of Life on an Active Subduction Zone, details field ... broad range of topics will be presented as scientists ...
(Date:9/21/2014)... global warming, are set to rise again in 2014 - ... 2.5 per cent projected rise in burning fossil fuels is ... the UK by researchers at the Tyndall Centre for Climate ... College of Engineering, Mathematics and Physical Sciences at the University ... Climate Summit, where world leaders will seek to catalyse action ...
(Date:9/21/2014)... MA -- Shellfish such as mussels and barnacles secrete ... or ship hulls, even underwater. Inspired by these natural ... materials that could be used to repair ships or ... their new waterproof adhesives, the MIT researchers engineered bacteria ... mussel proteins as well as a bacterial protein found ...
Breaking Biology News(10 mins):Geoscience topics in the spotlight -- Vancouver, BC 2Geoscience topics in the spotlight -- Vancouver, BC 3Geoscience topics in the spotlight -- Vancouver, BC 4Geoscience topics in the spotlight -- Vancouver, BC 5CO2 emissions set to reach new 40 billion ton record high in 2014 2CO2 emissions set to reach new 40 billion ton record high in 2014 3Engineered proteins stick like glue -- even in water 2Engineered proteins stick like glue -- even in water 3
... /PRNewswire-iReach/ -- Industry leader in healthcare operations decision ... the family waiting room experience.  While PatientStream,s electronic ... now offers a customizable multilingual whiteboard that can ... 3o languages are currently available, with more being ...
... antibiotic resistance correlates with oral ingestion of antibiotics, raising the ... of resistance. The manuscript appears online ahead of print ... "For more than 40 years, a few doses of ... says Hua Wang of the Ohio State University, Columbus, a ...
... to Research Careers) Program has announced the travel award ... MA from July 20-24, 2013. These awards are meant ... from underrepresented groups into the mainstream of the basic ... scientists at the 27th Protein Society Symposium. Awards ...
Cached Biology News:PatientStream announces the industry's first Multilingual family waiting room board 2PatientStream announces the industry's first Multilingual family waiting room board 3Antibiotics: Change route of delivery to mitigate resistance 2
... number of modifications of Grace's medium were ... 1960's and 1970's. Many of these modifications ... the growth of cells derived from the ... modification known as TNM-FH. The medium when ...
... optically clear polystyrene with frosted labeling ... for cell counting. 100% integrity tested. ... new product number, created to easily ... no availability yet, please order under ...
... This CLS number is ... to easily match Cornings product ... yet, please order under the ... contact customer service for assistance. ...
ABgene® supplies a 94kDa ultra-pure recombinant thermostable DNA polymerase obtained by high level expression of the Taq DNA polymerase gene in E. coli....
Biology Products: